Cancer Vaccines
Data on cancer vaccines detailed by researchers at University of Maryland
Published in Cancer Weekly, August 25th, 2009
"We conducted a clinical trial of peptide prostate specific antigen (PSA): 154-163 (155L) vaccination in human leukocyte antigen (HLA)-A2 patients with detectable and rising serum PSA after radical prostatectomy for prostate cancer (Clinicaltrials.gov identifier NCT00109811). The trial was a single dose-level, phase 2 pilot trial of 1 mg of PSA: 154-163 (155L) emulsified with adjuvant (Montanide ISA-51)," scientists writing in the Journal of Immunotherapy report.
"The primary end-point was the determination of immunogenicity of the vaccine; secondary outcomes were determination of toxicity and effect oil serum PSA. The vaccine was given Subcutaneously 7 times oil...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-08-25)
More Articles from Cancer Weekly
- Journal of the National Cancer Institute
The public overestimates benefits of cancer screening, survey finds - Wiley-Blackwell
Studies reveal hepatitis C virus carriers experience substantial increase in mortality - Cancer Vaccines
Data on cancer vaccines published by researchers at Yale University, Medical Department - Cancer Vaccines
New findings from N. Garciasierra and co-authors in the area of cancer vaccines published - Cancer Vaccines
Researchers from Kobe University, Medical Department detail findings in cancer vaccines - CombinatoRx, Incorporated
CombinatoRx Reports Financial Results for the Second Quarter 2009 - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
